First, the telomerase reverse transcriptase gene (TERT) was identified in GWAS studies, and by the analysis of a familial melanoma pedigree, a −57 bp mutation creating an ETS transcription factor binding site that activates the TERT promoter was identified 11. This evidence concerns the gene TERT and melanoma.